CVS (NYSE:CVS) has announced that in order to sharpen its focus on the health of its customers it will cease selling tobacco products by October of this year. The move will cost the company billions in sales, but could it cost the tobacco industry even more if other companies follow CVS' lead?

In this segment of the Motley Fool's consumer goods show, Consumer Countdown, CG analyst Michael Finarelli joins host Mark Reeth to discuss what lies ahead for CVS and if the company is about to take down Big Tobacco.

Mark Reeth has no position in any stocks mentioned. Michael Finarelli has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.